NEXI

NexImmune (NEXI) não distribuiu dividendos no último ano.

Currently, NexImmune (NEXI) is priced at US$ 0,00, with a P/E of 0,00%, representing a deviation of -0,58% from its historical average P/E. In the last year, the stock showed a variation of -99.97% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -99,97%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Investing in stocks of NexImmune (NEXI) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

The yield of NexImmune (NEXI) was -99,00% in the last month, -99,97% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of NexImmune (NEXI) today, the total investment would be US$ 0,01, based on the current price of US$ 0,00.

If past performance were to repeat, the return on your investment would be:

• In 1 year: US$ 0,00
• In 5 years: US$ 0,01
• In 10 years: 0,01

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.